EMA approves Novo Nordisk plan to store insulin at room temperature for longer

Novo Nordisk has received a positive opinion from the European Medicines Agency to store two types of insulin outside of the fridge for up to four weeks, which Novo states will improve flexibility in a number of low and middle income countries.

Photo: Novo Nordisk / PR

The European Medicines Agency (EMA) has approved an application from Novo Nordisk, allowing them to store Actrapid and Insulatard insulin doses outside of the refrigerator for up to four weeks. The insulin must still be stored at temperatures below 30 degrees Celsius.

A Novo Nordisk press release states that the positive scientific opinion from the EMA will be used to apply for more flexible national insulin storage guidelines in low and middle income countries, where the access to equipment needed to refrigerate the products can be limited.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs